Tag

Pretrial Order Archives - Carey Danis & Lowe

Transvaginal Mesh Lawyers at Carey Danis & Lowe Report on Ethicon MDL 2327 Pretrial Order 48

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsThe latest development in the Ethicon multidistrict litigation (MDL) in the U.S. District Court for the Southern District of West Virginia, U.S. District Judge Joseph R. Goodwin filed pretrial order 48 about dismissing certain Coloplast Corp. entities from all pending cases.

Filed on May 28, the pretrial order in Ethicon MDL 2327 reports on the defendants’ request for the removal of certain Coloplast entities from plaintiffs’ cases in all transvaginal mesh lawsuits consolidated into the five MDLs presided over by Judge Goodwin.

Though the pretrial order will have more of an affect on the Coloplast MDL 2387 itself, due to the closely related injuries detailed by plaintiffs, pretrial orders filed in one transvaginal mesh MDL in the West Virginia court are often filed in all of the MDLs.

The most recent pretrial order does not mean that the Coloplast MDL is being disbanded. Rather, it simply means that any mention of Coloplast subsidiaries, such as Coloplast A/S, Coloplast Manufacturing US, LLC, and Porges S.A., will be removed from plaintiffs’ cases.

Like Ethicon’s Gynecare Prolift vaginal mesh, Coloplast’s bladder sling has been linked to erosion, contraction, severe pelvic pain, infection, and other debilitating health complications.

Following almost 3,000 adverse event reports citing problems with vaginal mesh implants, the U.S. Food and Drug Administration (FDA) released a safety communication in July 2011 noting their continuing review of vaginal mesh products and studies.

According to the FDA’s review, the most frequently reported health complication related to vaginal mesh involves vaginal mesh erosion. The FDA communicated that to resolve vaginal mesh erosion, women underwent numerous surgeries, and even then, the vaginal mesh implant could not be entirely removed, leaving women in extreme pain and discomfort.

Transvaginal mesh lawyers at Carey Danis & Lowe are currently investigating vaginal mesh cases, and encourage individuals who have been injured by a vaginal mesh product, whether Ethicon’s Gynecare Prolift, Coloplast’s bladder slings, or another product, to contact one of our personal injury lawyers today for a free legal consultation.

 

Carey Danis & Lowe can also assist with filing vaginal mesh lawsuits. Contact Carey Danis & Lowe today by calling 800.721.2519 or by submitting a personal injury claim form.

Carey Danis & Lowe Evaluating Zoloft Cases and Offers an Update on Zoloft Lawsuits in Zoloft MDL No. 2342

By | Pharmaceutical litigation, Uncategorized, Zoloft

Published January 14, 2013 by PR Web

St. Louis, Missouri (PRWEB) January 14, 2013

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesZoloft lawsuits have been consolidated into a Multi-District Litigation in the U.S. District Court for the Eastern District of Pennsylvania. Judge Cynthia M. Rufe is presiding over the Zoloft MDL.

As to recent developments in the Zoloft MDL, on January 2, 2013, Judge Rufe sent forth Pretrial Order No. 16. Fundamentally, the Pretrial Order outlines how to deliver responses in the MDL. The court document imparts detailed information as to “the procedure for filing responses to all civil actions that are or become consolidated in MDL No. 2342”.*

The Pretrial Order goes on to supply information on how the defendants, Pfizer Inc., Greenstone LLC, and Pfizer International LLC, shall go about filing a Master Short-Form Answer. In essence, the Master-Short Form Answer and Affirmative Defense is the defendants’ response to the claims of the plaintiffs.

According to the Pretrial Order, the Defendants will only have the opportunity to file one Master Short-Form Answer, and in doing so can address any and all charges made against them in each of the cases consolidated in the Zoloft MDL. As the document will stand as their initial response to allegations, Pfizer and Greenstone can deny the plaintiffs’ allegations, and in so doing, they can lay out a defense.

If relying upon information supplied in a recent report, there are quite a number of Zoloft cases in the MDL, and therefore each of these cases will necessitate address in the defense’s response. A Florida attorney who sits on the Plaintiffs’ Steering Committee (PSC), Bryan F. Aylstock, recently submitted a report late last year regarding the status of the Zoloft MDL. The legal journal, The Madison-St. Clair Record, stated that according to information contained in Alystock’s report, there are over 250 cases that have been consolidated into the Zoloft MDL.*

Plaintiffs in the Zoloft MDL have filed lawsuits against Pfizer, the manufacturer of Zoloft, claiming that the antidepressant drug, classified as a selective serotonin re-uptake inhibitor (SSRI), causes birth defects in newborn children when taken by women during pregnancy.

In a separate Zoloft lawsuit being heard in the Wayne County Circuit Court in West Virginia, nineteen plaintiffs, who are the children of mothers who claimed to have taken Zoloft during pregnancy, filed their lawsuit alleging that exposure to Zoloft in the womb resulted in the development of their birth defects.

According to the legal journal, The West Virginia Record, the plaintiffs identified these Zoloft linked birth defects as heart defects, such as atrial septal defects and holes in the heart, persistent pulmonary hypertension of the newborn (PPHN), skull and facial deformations, and a number of other congenital birth defects related to Zoloft exposure in utero.*

Lawyers at Carey Danis & Lowe are currently evaluating Zoloft cases, and they are offering legal consultations to those individuals who claim to have been harmed by the use of Zoloft during pregnancy. For more information about filing a Zoloft lawsuit, and specifically one related to Zoloft and birth defects, contact a lawyer at Carey Danis & Lowe by calling 800-721-2519.